Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Clearside Biomedical, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- +1 vs. Q1 2021
- Shares held
- 19.7M
- +1.93M (+10.9%) vs. Q1 2021
- Total value
- $95.8M
- +$51.9M (+118.6%) vs. Q1 2021
- New holders
- 10
- 13 more added
- Sold out
- 9
- 15 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLSD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.26K |
| Q1 2026 | 1 | $7.87K |
| Q4 2025 | 1 | $19.1K |
| Q3 2025 | 26 | $2.18M |
| Q2 2025 | 45 | $7.51M |
| Q1 2025 | 44 | $8.09M |
| Q4 2024 | 44 | $8.97M |
| Q3 2024 | 49 | $12.7M |
| Q2 2024 | 49 | $17.9M |
| Q1 2024 | 52 | $23.8M |
| Q4 2023 | 48 | $9.06M |
| Q3 2023 | 46 | $6.82M |
| Q2 2023 | 54 | $9.62M |
| Q1 2023 | 51 | $9.09M |
| Q4 2022 | 53 | $10.2M |
| Q3 2022 | 54 | $13.6M |
| Q2 2022 | 53 | $20.1M |
| Q1 2022 | 60 | $37.5M |
| Q4 2021 | 67 | $57.8M |
| Q3 2021 | 66 | $121.5M |
| Q2 2021 | 53 | $95.8M |
| Q1 2021 | 52 | $43.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Clearside Biomedical, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 4,206,765 | $20.5M | 0.31% | 00.0% | Unchanged |
| Carmignac Gestion | 3,419,877 | $16.7M | 0.19% | −121,084−3.4% | Reduced |
| ACT Capital Management, LLC | 2,462,500 | $12.0M | 6.16% | +2,462,500 | New |
| Vanguard Group Inc | 2,106,090 | $10.3M | 0.00% | +378,559+21.9% | Added |
| Acuta Capital Partners, LLC | 1,316,268 | $6.41M | 2.74% | −297,732−18.4% | Reduced |
| Two Sigma Investments, LP | 1,085,475 | $5.29M | 0.01% | +363,267+50.3% | Added |
| Two Sigma Advisers, LP | 990,000 | $4.82M | 0.01% | +338,200+51.9% | Added |
| BlackRock Inc. | 771,558 | $3.76M | 0.00% | −101,552−11.6% | Reduced |
| Geode Capital Management, LLC | 423,541 | $2.06M | 0.00% | +58,818+16.1% | Added |
| Bridgeway Capital Management, LLC | 316,600 | $1.54M | 0.03% | +40,000+14.5% | Added |
| AJU IB Investment Co., Ltd. | 293,555 | $1.43M | 0.82% | −500,000−63.0% | Reduced |
| Morgan Stanley | 285,861 | $1.39M | 0.00% | −72,786−20.3% | Reduced |
| EAM Investors, LLC | 247,561 | $1.21M | 0.19% | +247,561 | New |
| Marshall Wace, LLP | 230,441 | $1.12M | 0.01% | −103,667−31.0% | Reduced |
| Millennium Management LLC | 175,035 | $852.0K | 0.00% | −11,346−6.1% | Reduced |
| First Manhattan Co | 175,000 | $852.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 165,588 | $806.0K | 0.00% | +125,848+316.7% | Added |
| QS Investors, LLC | 111,900 | $545.0K | 0.01% | 00.0% | Unchanged |
| Deutsche Bank AG | 104,527 | $509.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 87,806 | $428.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 70,589 | $344.0K | 0.00% | −493,910−87.5% | Reduced |
| Signaturefd, LLC | 54,177 | $264.0K | 0.01% | 00.0% | Unchanged |
| Ameritas Investment Company, LLC | 50,810 | $247.0K | 0.01% | +50,810 | New |
| Squarepoint Ops LLC | 41,663 | $203.0K | 0.00% | −58,894−58.6% | Reduced |
| Citadel Advisors LLC | 38,653 | $188.0K | 0.00% | +13,728+55.1% | Added |
| Susquehanna International Group, LLP | 37,755 | $184.0K | 0.00% | −107,325−74.0% | Reduced |
| Price T Rowe Associates Inc | 37,200 | $181.0K | 0.00% | −12,400−25.0% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 30,200 | $147.0K | 0.00% | −1,200−3.8% | Reduced |
| Charles Schwab Investment Management Inc | 28,221 | $138.0K | 0.00% | +16,293+136.6% | Added |
| Synovus Financial Corp | 28,071 | $136.0K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 26,656 | $130.0K | 0.00% | +6,056+29.4% | Added |
| Curi Capital | 25,000 | $121.0K | 0.06% | 00.0% | Unchanged |
| Caxton Associates LP | 24,677 | $120.0K | 0.02% | +24,677 | New |
| Private Advisor Group, LLC | 23,500 | $114.0K | 0.00% | −1,500−6.0% | Reduced |
| Bank of New York Mellon Corp | 19,103 | $93.0K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 18,000 | $88.0K | 0.00% | +18,000 | New |
| Goldman Sachs Group Inc | 16,766 | $82.0K | 0.00% | +16,766 | New |
| Integrated Advisors Network LLC | 15,700 | $76.0K | 0.01% | 00.0% | Unchanged |
| Wolverine Trading, LLC | 15,910 | $76.0K | 0.00% | +15,910 | New |
| Stifel Financial Corp | 14,494 | $71.0K | 0.00% | −4,250−22.7% | Reduced |
| Exencial Wealth Advisors, LLC | 14,064 | $68.0K | 0.00% | 00.0% | Unchanged |
| Northeast Financial Consultants Inc | 10,000 | $49.0K | 0.00% | 00.0% | Unchanged |
| Vestor Capital, LLC | 9,000 | $44.0K | 0.00% | +9,000 | New |
| JPMorgan Chase & Co | 7,500 | $37.0K | 0.00% | +2,500+50.0% | Added |
| Advisor Group Holdings, Inc. | 7,400 | $36.0K | 0.00% | +5,000+208.3% | Added |
| UBS Group AG | 6,566 | $32.0K | 0.00% | +566+9.4% | Added |
| The PNC Financial Services Group, Inc. | 5,586 | $27.0K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 3,500 | $17.0K | 0.00% | +3,500 | New |
| Bank of America Corp | 2,891 | $14.0K | 0.00% | −1,442−33.3% | Reduced |
| Parallel Advisors, LLC | 2,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 372 | $2.00K | 0.00% | +76+25.7% | Added |
| Harbour Investments, Inc. | 400 | $2.00K | 0.00% | +400 | New |
| BNP Paribas Arbitrage, SA | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −165,330−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −121,317−100.0% | Sold out |
| Newman Dignan & Sheerar, Inc. | 0 | $0 | 0.00% | −23,023−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,885−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,206−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −17,045−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −16,672−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −812−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |